Albert Einstein College of Medicine
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, Albert Einstein College of Medicine sits in the top decile of US sponsors by registered trial count (#169 of 15,742 sponsors by registered trial count).
Albert Einstein College of Medicine: 175 sponsored US clinical trials, 20 recruiting.
Albert Einstein College of Medicine sponsors 175 registered US clinical trials on ClinicalTrials.gov, 20 of them currently recruiting, and 121 completed. 17 of these trials are in Phase 3-4 (later-stage) and 49 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Chronic Pain, with 5 trials.
Top-decile sponsor footprint
Albert Einstein College of Medicine ranks in the top decile of sponsors by registered trial count (#169 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
121 of 148 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (81.8%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
175 total, page 3 of 4
Wellness Program Implementation: School & Student Toolkits
NCT02277496
PET-Adjusted Intensity Modulated Radiation Therapy and Combination Chemotherapy in Treating Patients With Stage II-IV Non-small Cell Lung Cancer
NCT02073968
Chemotherapy Before Surgery and Tissue Sample Collection in Patients With Stage IIA-IIIC Breast Cancer
NCT01897441
Effectiveness and Feasibility of Patient Controlled Analgesia in the ED
NCT01775371
A Trial To Study The Effects Of Group Versus Individual Dietary Counseling In Pediatric Obesity
NCT01840631
Immunotoxin Therapy and Cytarabine in Treating Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia
NCT01408160
Neurocognitive Effects of Opiate Agonist Treatment
NCT01733693
Liraglutide Versus Insulin Mono-therapy in the Closed Loop Setting
NCT01755416
Comparison of Standard Versus Low Bicarbonate Hemodialysis
NCT01777178
Pilot Test of a Community-based Buprenorphine Treatment Intervention
NCT01761110
Phase II Study of Lenalidomide and Eltrombopag in Patients With Symptomatic Anemia
NCT01772420
Efficacy of Group Attachment Based Intervention for Vulnerable Families
NCT01641744
Cardiac Surgery Neuroprotection Study in Elders
NCT01561378
Bi-Level Positive Airway Ventilation for Acute Chest Syndrome
NCT01589926
Project FIRST - Financial Incentives to Reduce Substance Use and Improve Treatment
NCT01376570
Treatment of Strongyloides Infection
NCT03605758
Chinese Diabetes Prevention Program (Chinese DPP)
NCT02277509
Busulfan, Melphalan, and Bortezomib Before First-Line Stem Cell Transplant in Treating Patients With Multiple Myeloma
NCT01605032
Effect of Obstructive Sleep Apnea Syndrome on Insulin Sensitivity and Cardiovascular Risk in PCOS Adolescents
NCT01840618
Gemcitabine Hydrochloride, and Radiation Therapy in Patients With Borderline Resectable Pancreatic Cancer
NCT01897454
Sitagliptin Dose Determination Study
NCT01530178
HIPEC for Peritoneal Carcinomatosis
NCT02040142
Arm Circumference Measurement With or Without Bioimpedance Spectroscopy in Finding Lymphedema Early in Patients With Stage I-III Breast Cancer
NCT03648983
Association Between Body Size and Response to Hydromorphone in ED
NCT01675778
Alkali Therapy in Chronic Kidney Disease
NCT01452412
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With Uterine Cancer
NCT01367301
Varenicline Smoking Cessation Treatment for Methadone Maintenance Patients
NCT01378858
Pilot Study of Resveratrol in Older Adults With Impaired Glucose Tolerance
NCT01375959
Closed Loop System With Pramlintide Versus Exenatide
NCT01269008
New Onset Type 1 Diabetes: Role of Exenatide
NCT01269034
Effect of GLP-1 on Insulin Biosynthesis and Turnover Rates
NCT00609154
LUCHAR - Latinos Using Counseling for Help With Asthma and Anxiety Reduction
NCT01583296
Sickle Cell Trait and the Risk of Venous Thromboembolism
NCT01148940
Meditation-Based Breathing Training in Improving Target Motion Management and Reducing Distress in Patients With Abdominal or Lung Cancer Undergoing Radiation Therapy
NCT01939210
Neurocognitive Effects of Buprenorphine Among HIV+ and HIV-Opioid Users
NCT01108679
The Effects of Vitamin D Repletion in Vitamin D Deficient Patients With Stage 3 and 4 Chronic Kidney Disease
NCT01029002
Smoking Cessation Treatment for Methadone Maintenance Patients
NCT01027754
Use of Exenatide and Pramlintide to Decrease Post-prandial Hyperglycemia
NCT01269047
Project Prepared: Risks, Roles and Relationships
NCT01880450
Safety and Efficacy of Patient Controlled Analgesia in the Emergency Department
NCT00910208
Effect of Vitamin D Repletion on Insulin Resistance and Systemic Inflammation
NCT01354964
Sodium Bicarbonate Supplementation in Chronic Kidney Disease Evaluation of Dose Response, Safety and Beneficial Effects
NCT00888290
Radiation Therapy, Paclitaxel, and Carboplatin in Treating Patients With High-Risk Endometrial Cancer
NCT01041027
Intravenous Gammaglobulin for Sickle Cell Pain Crises
NCT01757418
Allergy Immunotherapy for the Reduction of Asthma
NCT01028560
Bronx A1c: Bring it Down for Health
NCT00797888
Copper Intrauterine Device (IUD) Insertion at Cesarean Delivery
NCT01439802
Pemetrexed and Carboplatin in Treating Patients With Recurrent Ovarian, Primary Peritoneal, or Fallopian Tube Cancer
NCT01001910
A Randomized Trial of The Effectiveness of Aromatherapy on Chemotherapy Induced Nausea and Vomiting in Children With Cancer
NCT00754286
Acupuncture for Chronic Pain
NCT01149317
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 20 |
| Phase 2 | 29 |
| Phase 3 | 5 |
| Phase 4 | 12 |
Therapeutic Areas
What is open in the Albert Einstein College of Medicine pipeline
20 recruiting of 175 indexed (11% open); 121 completed (69%).
Phase mix: 17 late (III/IV) vs 49 early (I/II) (early-phase heavy).
Top condition: Chronic Pain (5 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
Albert Einstein College of Medicine: open-pipeline peers nationwide
Peers matched on 175 registered trials and 11% open enrollment, not the therapeutic-area sidebar.
Albert Einstein College of Medicine sits below the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 175 trials (± recruiting share)
- Bausch & Lomb Incorporated · 174 trials · 2% recruiting
- UConn Health · 178 trials · 11% recruiting
- Baylor Research Institute · 180 trials · 17% recruiting
- Abbott · 181 trials · 0% recruiting
Sponsors near 11% open enrollment (± trial volume)
- University of Memphis · 11% recruiting · 35 trials
- Children's Mercy Hospital Kansas City · 11% recruiting · 184 trials
- Janssen Research & Development · 11% recruiting · 593 trials
- Barbara Ann Karmanos Cancer Institute · 12% recruiting · 139 trials
Related
What to do with this Albert Einstein College of Medicine page
175 registered trials is a research-attention snapshot, not an endorsement of Albert Einstein College of Medicine or any single study.
- 20 of Albert Einstein College of Medicine's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Chronic Pain is the condition Albert Einstein College of Medicine studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Chronic Pain trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. Albert Einstein College of Medicine pipeline card: 175 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.